Ticker Details
Amgen Inc. Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.
IPO Date:	January 2, 1990
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$197.69B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.66 | 1.11%
Avg Daily Range (30 D):	$4.04 | 1.14%
Avg Daily Range (90 D):	$3.86 | 1.11%

Institutional Daily Volume
Avg Daily Volume:	4.72M
Avg Daily Volume (30 D):	1.87M
Avg Daily Volume (90 D):	1.78M

Trade Size
Avg Trade Size (Sh.):	127
Avg Trade Size (Sh.) (30 D):	31
Avg Trade Size (Sh.) (90 D):	30

Institutional Trades
Total Institutional Trades:	115,491
Avg Institutional Trade:	$6.74M
Avg Institutional Trade (30 D):	$44.69M
Avg Institutional Trade (90 D):	$42.47M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	20

Market Closing Trades
Avg Closing Trade:	$70.42M
Avg Closing Trade (30 D):	$263.78M
Avg Closing Trade (90 D):	$225.89M
Avg Closing Volume:	396.14K

News

Jul 20, 2026 @ 7:15 AM Could Pfizer Ultimately Be the Biggest Winner in t... Source: Prosper Junior Bakiny

Jul 17, 2026 @ 10:48 AM Clinical Stage Partnering Terms and Agreements in ... Source: Researchandmarkets.Com

Jul 15, 2026 @ 9:00 PM Landmark ECOG-ACRIN ENDURANCE Study Co-Authored by... Source: International Myeloma Foundation

Jul 15, 2026 @ 3:00 PM Autoimmune Disease Therapeutics Market Size to Rea... Source: Sns Insider

Jul 12, 2026 @ 7:30 PM Biotech ETFs: How Do FBT and IBB Match Up on Cost,... Source: Jake Lerch

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$14.48	$3.37	$2.47
Diluted EPS	$14.38	$3.34	$2.46
Revenue	$37.22B	$8.62B	$9.87B
Gross Profit	$25.41B	$5.87B	$6.89B
Net Income / Loss	$7.8B	$1.82B	$1.33B
Operating Income / Loss	$10.57B	$2.67B	$2.72B
Cost of Revenue	$11.81B	$2.74B	$2.98B
Net Cash Flow	$3.23B	$2.91B	$-316M
PE Ratio